Neurology· Topic 10.8 Central nervous system infections· 10.8.8

Japanese encephalitis

Japanese encephalitis is a mosquito-borne flavivirus infection and the leading vaccine-preventable cause of viral encephalitis in Asia, confirmed by cerebrospinal fluid IgM antibody testing and managed with supportive care plus empiric acyclovir until herpes simplex encephalitis is excluded.

12 min read12 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    The most prevalent vaccine-preventable cause of infectious encephalitis in Asia: Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, is endemic throughout most of Asia and parts of the western Pacific.

  • Epidemiology

    Geographic distribution across Asia and the western Pacific: JEV is the leading cause of epidemic viral encephalitis in this region.

  • Risk factors

    Prolonged travel or residence in an endemic area, especially rural or agricultural regions: extended stays with outdoor evening exposure carry the highest risk.

  • Pathophysiology

    Mosquito-borne flaviviral inoculation followed by viremia: Culex mosquitoes transmit JEV via bite; most infections remain confined to peripheral replication and asymptomatic seroconversion.

  • Clinical features

    Nonspecific febrile prodrome with headache, followed rapidly by neurologic decline: the illness begins as an undifferentiated viral-like syndrome and progresses quickly to an encephalopathic state…

  • Differential diagnosis

    Herpes simplex virus (HSV) encephalitis: the most common cause of sporadic encephalitis in regions without endemic arboviral transmission, distinguished by unilateral temporal lobe edema or…

  • Diagnosis

    The diagnosis is confirmed by detection of virus-specific IgM antibodies in the cerebrospinal fluid, later also detectable in serum; there is no formal severity grading system for Japanese…

  • Management

    First, start empiric intravenous acyclovir while HSV encephalitis is being excluded: acyclovir 10 mg/kg IV every 8 hours for at least 14 to 21 days if HSV is confirmed, with prompt discontinuation…

  • Complications

    Permanent neurologic sequelae: survivors of severe encephalitis can be left with persistent motor deficits, cognitive impairment, or movement disorders from thalamic and basal ganglia injury.

  • Prognosis

    Mortality of 20% to 30% among those with symptomatic encephalitis: this reflects the subset who progress beyond asymptomatic or mild infection, not overall infected persons, since fewer than 1% of infections become clinically apparent.

  • Prevention

    Two-dose inactivated JEV vaccine for travelers with qualifying risk: in the United States, an inactivated vaccine is available and recommended for travelers to endemic areas based on individual risk…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.